CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −4,515 | $31.95 | $144K | 380,038 |
| 2024-04-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −7,977 | $38.15 | $304K | 247,917 |
| 2024-04-01 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +1,000 | $3.95 | $4K | 87,312 |
| 2024-04-01 | Schlanger David J Executive Chairman | Shares withheld for taxes 10b5-1 | −2,681 | $38.15 | $102K | 84,631 |
| 2024-04-01 | Schlanger David J Executive Chairman | Sale 10b5-1 | −1,000 | $37.52 | $38K | 83,631 |
| 2024-04-01 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,000 | 1,309,022 | ||
| 2024-04-01 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −4,515 | $37.60 | $170K | 386,433 |
| 2024-04-01 | Sturmer Michael E PRESIDENT | Sale 10b5-1 | −1,880 | $37.60 | $71K | 384,553 |
| 2024-04-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +20,627 | $3.95 | $81K | 72,875 |
| 2024-04-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes 10b5-1 | −11,591 | $37.64 | $436K | 61,284 |
| 2024-04-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,129 | $37.60 | $80K | 59,155 |
| 2024-04-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −9,036 | $37.62 | $340K | 50,119 |
| 2024-04-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −20,627 | 0 | ||
| 2024-03-27 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +71,272 | $3.95 | $282K | 157,584 |
| 2024-03-27 | Schlanger David J Executive Chairman | Sale 10b5-1 | −71,272 | $37.80 | $2.7M | 86,312 |
| 2024-03-27 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −71,272 | 1,310,022 | ||
| 2024-03-26 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +305 | $3.95 | $1K | 86,617 |
| 2024-03-26 | Schlanger David J Executive Chairman | Sale 10b5-1 | −305 | $37.50 | $11K | 86,312 |
| 2024-03-26 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −305 | 1,381,294 | ||
| 2024-03-25 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +2,597 | $3.95 | $10K | 88,909 |
Page 13 of 77 · 1,524 trades